Oxymatrine-carbenoxolone sodium inclusion compound induces antinociception and increases the expression of GABAAα1 receptors in mice

European Journal of Pharmacology

Volumn 626, Issue 2-3, 2010, Pages 244-249

  Zhou, Junjun ^a   Yang, Guang ^b   Jin, Shaoju ^b   Tao, Lijun ^b   Yu, Jianqiang ^b   Jiang, Yuanxu ^b  

^a Shandong Xinshidai Medicine Industry Co Ltd   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Analgesia; GABA; GABAA; OCSIC

Indexed keywords

4 AMINOBUTYRIC ACID A ALPHA 1 RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR; ACETIC ACID; ACETYLSALICYLIC ACID; ANALGESIC AGENT; FORMALDEHYDE; MORPHINE; OXYMATRINE CARBENOXOLONE SODIUM INCLUSION COMPOUND; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SCREENING; HOT PLATE TEST; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE; TAIL FLICK TEST;

ABDOMINAL MUSCLES; ACETIC ACID; ALKALOIDS; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; CARBENOXOLONE; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMERSION; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MICE; MICE, INBRED ICR; MUSCLE CONTRACTION; PAIN; POSTERIOR HORN CELLS; QUINOLIZINES; RECEPTORS, GABA-A; TAIL; TEMPERATURE;

EID: 70649096987     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.09.065     Document Type: Article

References (37)

1. Chau T. Pharmacological Methods in the Control of Inflammation. In: Chang J.Y., and Lewis A.J. (Eds). Modern Methods in Pharmacology (1989), A. R. Liss, New York, NY 195-212
2. Corrêa C.R., and Calixto J.B. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br. J. Pharmacol. 110 (1993) 193-198
3. Collier H.O., Dinneen L.C., Johnson C.A., and Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br. J. Pharmacol. Chemother. 32 (1968) 295-310
4. Condés-Lara M., Rojas-Piloni G., Martínez-Lorenzana G., López-Hidalgo M., and Rodríguez-Jiménez J. Hypothalamospinal oxytocinergic antinociception is mediated by GABAergic and opiate neurons that reduce A-delta and C fiber primary afferent excitation of spinal cord cells. Brain Res. 1247 (2009) 38-49
5. Crestani F., Martin J.R., Mohler H., and Rudolph U. Mechanism of action of the hypnotic zolpidem in vivo. Brit. J. Pharmacol. 131 (2000) 1251-1254
6. Dai X.J., Liu L.J., Jiang Y.X., and Jin S.J. Preparation of oxymatrine-carbenoxolone sodium complex and its pharmacological activity. Chinese Traditional and Herbal Drugs 38 (2007) 44-46 (Article in Chinese)
7. Dongmo A.B., Nguelefack T., and Lacaille-Dubois M.A. Antinociceptive and anti-inflammatory activities of Acacia pennata wild (Mimosaceae). J. Ethnopharmacol. 98 (2005) 201-206
8. Eddy N.B., and Leimbach D. Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107 (1953) 385-393
9. Goyal R., and Anil K. Protective effect of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations in mice. Pharmacol. Rep. 59 (2007) 284-290
10. Grant G.J., Vermeulen K., Zakowski M.I., Stenner M., Turndorf H., and Langerman L. Prolonged analgesia and decreased toxicity with liposomal morphine in a mouse model. Anesth. Analg. 79 (1994) 706-709
11. Hendershot L.C., and Forsaith J. Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and nonanalgesics. J. Pharmacol. Exp. Ther. 125 (1959) 237-240
12. Hunskaar S., and Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30 (1987) 103-114
13. 4 in mice. J. Ningxia Med. Coll. 27 (2005) 272-273 (Article in Chinese)
14. Koster R., Anderson M., and DeBeer E.J. Acetic acid for analgesic screening. Fed. Proc. 18 (1959) 412-416
15. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacol. Rev. 53 (2001) 597-652
16. Li ZH.R. The pharmaceutical effect and clinical development of kushenin. West China Pharmacal Journal 18 (2003) 435-437 (Article in Chinese)
17. Lujan R. Subcellular regulation of metabotropic GABA receptors in the developing cerebellum. Cerebellum 6 (2007) 123-129
18. Martire M., Castaldo P., D'Amico M., Preziosi P., Annunziato L., and Taglialatela M. M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals. J. Neurosci. 24 (2004) 592-597
19. Melzack R., and Wall P.D. Pain mechanism: a new theory. Science 150 (1965) 971-979
20. Mohler H., Fritschy J.M., and Rudolph U. A new benzodiazepine pharmacology. J. Pharmacol. Exp. Ther. 300 (2002) 2-8
21. Morteza-Semnani K., Saeedi M., Hamidian M., Vafamehr H., and Dehpour A.R. Anti-inflammatory, analgesic activity and acute toxicity of Glaucium grandiflorum extract. J. Ethnopharmacol. 80 (2002) 181-186
22. Nadeson R., Guo Z., Porter V., Gent J.P., and Goodchild C.S. Gamma-Aminobutyric acid A receptors and spinally mediated antinociception in rats. J. Pharmacol. Exp. Ther. 278 (1996) 620-626
23. Naum O.G., Fernanda M., and Golombek D.A. Rhythmic variation in gamma-aminobutyric acid (A)-receptor subunit composition in the circadian system and median eminence of Syrian hamsters. Neurosci. Lett. 310 (2001) 178-182
24. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W., and Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101 (2000) 815-850
25. A receptor subunits in widespread brain regions in the freeze-lesion model of focal cortical malformations. J. Neurosci. 20 (2000) 5045-5053
26. Rujjanawate C., Kanjanapothi D., and Panthong A. Pharmacological effect and toxicity of alkaloids from Gelsemium elegans Benth. J. Ethnopharmacol. 89 (2003) 91-95
27. Santos A.R., and Calixto J.B. Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice. Neuropeptides 31 (1997) 381-389
28. Sieghart W., and Sperk G. Subunit composition, distribution and function of GABA (A) receptor subtypes. Curr. Top. Med. Chem. 2 (2002) 795-816
29. Thomsen M., Wortwein G., Olesen M.V., Begtrup M., Havez S., Bolwig T.G., and Woldbye D.P. Involvement of Y(5) receptors in neuropeptide Y agonist-induced analgesic-like effect in the rat hot plate test. Brain Res. 1155 (2007) 49-55
30. Tjølsen A., Berge O.G., Hunskaar S., Rosland J.H., and Hole K. The formalin test: an evaluation of the method. Pain 51 (1992) 5-17
31. Vaz Z.R., Filho V.C., Yunes R.A., and Calixto J.B. Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4, 6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of nociception in mice. J. Phamacol. Exp. Ther. 278 (1996) 304-312
32. Wall P.D. The substantia gelatinosa. A gate control mechanism set across sensory pathway. Trends Neurosci. 3 (1980) 221-224
33. Walwyn W.M., Matsuka Y., Arai D., Bloom D.C., Lam H., Tran C., Spigelman I., and Maidment N.T. HSV-1-mediated NGF delivery delays nociceptive deficits in a genetic model of diabetic neuropathy. Exp. Neurol. 198 (2006) 260-270
34. Wang J.X., and Wang G.J. Pharmacological action and clinical application of matrine and oxymatrine. Chinese Hepatol. 5 (2000) 116-117 (Article in Chinese)
35. Xu S.Y., Bian R.L., and Chen X. Pharmacological Experiment Methods. Third ed (1991), People Medicion Publitation, Beijing pp. 702 (Article in Chinese)
36. Yan L., Jiang Y.X., and Yao W.X. Studies of analgesia effect of oxysophoridine. Chinese Traditional and Herbal Drugs 37 (2006) 1061-1062 (Article in Chinese)
37. Yao X.C., Tian CH.X., and Chen W. The recently development of enoxolone and its derivant. J. Nongken Med. Sci. 26 (2004) 304-307 (Article in Chinese)